Integrated Smoking Cessation and Mood Management for ACS Patients
| Status: | Withdrawn |
|---|---|
| Conditions: | Smoking Cessation, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 8/30/2017 |
| Start Date: | February 1, 2017 |
| End Date: | December 1, 2017 |
Integrated Smoking Cessation and Mood Management for ACS Patients (PACES Phase IV Vanguard R56 Trial)
Quitting smoking following acute coronary syndrome can reduce mortality up to 50%. However,
depression and smoking are highly co-morbid and depressed mood may interfere with cessation
and independently predicts mortality. Thus, a single, integrated treatment for both smoking
and depression could be highly effective in reducing post-acute coronary syndrome mortality.
Behavioral Activation (BA) is a well established treatment for depression and has recently
shown promise as a treatment for smoking cessation. The investigators systematically
developed an intervention integrating gold standard smoking cessation counseling with
existing BA based mood management techniques for post-ACS smokers; Behavioral Activation
Treatment for Cardiac Smokers (BAT-CS).
Objective: For this R56 the investigators will conduct a vanguard trial to pilot all methods,
materials, and systems for the later fully powered BAT-CS vs. attention control trial. The
investigators will enroll up to 36 smokers with ACS and randomize them to 12 weeks of BAT-CS
or an attention control (Health and Wellness Education). Both groups will be offered the
nicotine patch if medically safe.
depression and smoking are highly co-morbid and depressed mood may interfere with cessation
and independently predicts mortality. Thus, a single, integrated treatment for both smoking
and depression could be highly effective in reducing post-acute coronary syndrome mortality.
Behavioral Activation (BA) is a well established treatment for depression and has recently
shown promise as a treatment for smoking cessation. The investigators systematically
developed an intervention integrating gold standard smoking cessation counseling with
existing BA based mood management techniques for post-ACS smokers; Behavioral Activation
Treatment for Cardiac Smokers (BAT-CS).
Objective: For this R56 the investigators will conduct a vanguard trial to pilot all methods,
materials, and systems for the later fully powered BAT-CS vs. attention control trial. The
investigators will enroll up to 36 smokers with ACS and randomize them to 12 weeks of BAT-CS
or an attention control (Health and Wellness Education). Both groups will be offered the
nicotine patch if medically safe.
Inclusion Criteria:
1. hospital inpatients with an ACS diagnosis documented in medical record,
2. smoked 1 or more cigarettes per day before being hospitalized,
3. age of 18-75,
4. English fluency,
5. lives within a 1 hour drive of the admitting hospital and has no plans to move away
from the area for 1 year,
6. willing to consider quitting smoking at discharge,
7. has telephone, and
8. willing to consent to all study procedures.
Exclusion Criteria:
1. limited mental competency (i.e., Mini Mental Status Exam score ≤ 23);
2. presence of severe mental illness that would interfere with participation (e.g.,
schizophrenia) or suicidality;
3. expected discharge to hospice; and
4. currently attending counseling for depression or smoking cessation.
We found this trial at
1
site
Miriam Hospital The Miriam Hospital is a private, not-for-profit hospital, with a history of providing...
Click here to add this to my saved trials
